Lufax (NYSE:LU – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.08 by ($1.12), FiscalAI reports. The company had revenue of $916.61 million during the quarter, compared to analysts’ expectations of $2.22 billion.
Here are the key takeaways from Lufax’s conference call:
- Reporting and governance have been restored: Lufax completed audits through 2025, brought SEC filings current, regained NYSE listing compliance, strengthened internal controls, and appointed a Chief Compliance Officer. Hong Kong-listed ordinary shares, however, remain suspended pending further discussions with the exchange.
- Total new loan sales rose 4.6% year over year to RMB 51.1 billion, led by a 27.6% increase in consumer finance loans. This was offset by a 13.5% decline in outstanding balances and a 15.5% drop in total income as small-business demand remained weak.
- Asset quality improved sequentially: The CM3 flow rate declined to 1.0% from 1.2%, the non-consumer-finance 30+ delinquency rate fell to 5.8%, and consumer-finance NPLs improved to 1.3%. Management expects the improvement to continue in the second half of 2026, though credit costs remain elevated.
- Lufax remained loss-making as weak small-business conditions, elevated credit costs, interest-rate compression, and tighter rules limiting high-priced lending weighed on profitability. Management acknowledged near-term pressure on both growth and margins.
- Over the next two to three years, Lufax plans to emphasize lower-risk customers, expand consumer finance as a second growth engine, revive small-business lending through industry- and region-specific products, and use AI to reduce acquisition, risk-control, collection, and operating costs.
Lufax Trading Down 4.2%
NYSE:LU opened at $1.47 on Thursday. The company has a market capitalization of $1.27 billion, a P/E ratio of -1.88 and a beta of 0.81. The firm has a 50-day moving average price of $1.41 and a two-hundred day moving average price of $1.86. Lufax has a twelve month low of $1.20 and a twelve month high of $4.57.
Institutional Trading of Lufax
Wall Street Analyst Weigh In
LU has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised shares of Lufax from a “neutral” rating to an “overweight” rating and set a $2.00 target price on the stock in a report on Tuesday, July 28th. Zacks Research downgraded Lufax from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Lufax in a report on Thursday, August 13th. Finally, Wall Street Zen raised Lufax from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. One investment analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $2.00.
View Our Latest Analysis on Lufax
Lufax Company Profile
Lufax (NYSE: LU) is a leading provider of online wealth management and personal finance services in China. Established in 2011 as a spin-off from Ping An Insurance (Group) Company of China, Lufax has developed a digital ecosystem designed to match retail and institutional investors with a diverse array of financial products. The company went public on the New York Stock Exchange in October 2020, underscoring its ambition to expand beyond its domestic market.
The firm’s core business activities include peer-to-peer lending, consumer finance, supply chain and small-business lending, as well as online asset management.
Recommended Stories
- Five stocks we like better than Lufax
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Receive News & Ratings for Lufax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lufax and related companies with MarketBeat.com's FREE daily email newsletter.
